<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An understanding of the <z:mp ids='MP_0001532'>physiology</z:mp> of vascular smooth muscle and knowledge of the reaction of such muscle to certain drugs are essential for the development of a means of treating <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral arterial spasm</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The role of <z:chebi fb="0" ids="23447">cyclic nucleotides</z:chebi> in vascular smooth muscle activity is reviewed and possible therapeutic approaches are listed </plain></SENT>
<SENT sid="2" pm="."><plain>Probably the safest and most effective treatment would be 1) stimulation of the adenyl cyclase-cyclic <z:chebi fb="3" ids="16335">adenosine</z:chebi> monophosphate system by a beta(2)-<z:chebi fb="0" ids="37962">adrenergic drug</z:chebi> combined with 2) inhibition of the phosphodiesterase system </plain></SENT>
</text></document>